Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 2

Status

Withdrawn 2Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Head & Neck 5

Conditions

Prostatic Neoplasms 19Lung Neoplasms 18Breast Neoplasms 12Multiple Myeloma 10Carcinoma, Non-Small-Cell Lung 9Leukemia, Myeloid, Acute 8Rectal Neoplasms 7Carcinoma, Hepatocellular 7Myelodysplastic Syndromes 6Mouth Neoplasms 6Sarcoma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Pancreatic Neoplasms 5Oropharyngeal Neoplasms 5Neoplasms 5Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myelomonocytic, Chronic 5Head and Neck Neoplasms 5Brain Neoplasms 5Ovarian Neoplasms 4Melanoma 4Lymphoma, B-Cell 4Leukemia, Biphenotypic, Acute 4Glioma 4Fallopian Tube Neoplasms 4Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Lymphoma, T-Cell 3Lymphoma, Non-Hodgkin 3Laryngeal Neoplasms 3

Interventions

Cisplatin 43Radiotherapy 27Radiotherapy, Intensity-Modulated 24Radiation 16Carboplatin 14Surveys and Questionnaires 13Magnetic Resonance Spectroscopy 13Cetuximab 11Surgical Procedures, Operative 10pembrolizumab 9Specimen Handling 8Chemoradiotherapy 8Drug Therapy 7Docetaxel 7Biopsy 71,2-diaminocyclohexaneplatinum II citrate 7Platinum 6Paclitaxel 6Fluorouracil 6durvalumab 5X-Rays 5Observation 5Blood Specimen Collection 5Standard of Care 4Nivolumab 4Immunohistochemistry 4Celecoxib 4Taxes 3Neck Dissection 3Liquid Biopsy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Oropharyngeal Neoplasms × X-Rays × Clear all
NCT06997068 2026-05-11

Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population

Mayo Clinic

Phase 2 Recruiting
25 enrolled
Head & Neck

Carcinoma, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT05075980 2026-04-13

Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study

Mayo Clinic

Phase 2 Active not recruiting
174 enrolled
Head & Neck

Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Lymphatic Metastasis, Mouth Neoplasms, Oropharyngeal Neoplasms, Paranasal Sinus Neoplasms, Salivary Gland Neoplasms

NCT04498221 2024-09-19

LOOC

University College, London

Phase NA Recruiting
150 enrolled
Head & Neck

Oropharyngeal Neoplasms

NCT05512767 2023-01-06

A Pneumatic Compression Device for the Treatment of Lymphedema in Patients With Stage II-IV Head and Neck Cancer After Chemoradiation

Mayo Clinic

Phase NA Withdrawn
Head & Neck

Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT01767961 2017-08-10

Modified Barium Swallow in Measuring Swallowing Function After Surgery in Patients With Oropharyngeal Cancer

Wake Forest University Health Sciences

Phase NA Withdrawn
Head & Neck

Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡